Literature DB >> 8797895

Effect of heavy alcohol intake on long-term results after curative resection of hepatitis C virus-related hepatocellular carcinoma.

S Okada1, H Ishii, H Nose, T Okusaka, A Kyogoku, M Yoshimori, K Shimada, J Yamamoto, T Kosuge, S Yamasaki, M Sakamoto, S Hirohashi.   

Abstract

We studied the effect of heavy alcohol intake (ethanol intake > or = 80 g/day for > or = 5 yr) on long-term results in 53 patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) who had undergone curative hepatic resection. Cell proliferative activity in the tumor and non-tumorous liver was also assessed by counting argyrophilic nucleolar organizer region-associated proteins (Ag-NOR) in the resected specimens. Twenty patients (20 males, 0 females) were positive for heavy alcohol intake [AI(+)] and 33 (28 males, 5 females) were not [AI(-)]. All patients were positive for HCV antibody and negative for hepatitis B surface antigen. Carcinoma recurred within 3 to 51 postoperative months in 42 (79.2%) of the 53 patients. The median disease-free survival time was 12.6 mo in the AI(+) group and 25.4 mo in the AI(-) group (P < 0.01). The AI(+) group also had significantly poorer survival than the AI(-) group (P < 0.05, 3-year survival rate: 66.7% vs. 93.5%). HCC tumor in the AI(+) group showed significantly increased proliferative activity compared with that in the AI(-) group (P < 0.05, Ag-NOR number: 2.3 +/- 0.8 vs. 1.9 +/- 0.4). However, there was no significant difference between the numbers of Ag-NORs in non-tumorous liver from these two groups (1.5 +/- 0.2 vs. 1.5 +/- 0.2). Patients with heavy alcohol intake should be followed particularly closely, even if they have received curative surgery, since heavy alcohol intake is closely related to a poor postoperative prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797895      PMCID: PMC5921169          DOI: 10.1111/j.1349-7006.1996.tb02113.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


alcohol intake argyrophilic nucleolar organizer region hepatocellular carcinoma hepatitis C virus
  19 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

3.  Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C.

Authors:  M Oshita; N Hayashi; A Kasahara; H Hagiwara; E Mita; M Naito; K Katayama; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

4.  Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury.

Authors:  A Parés; J M Barrera; J Caballería; G Ercilla; M Bruguera; L Caballería; R Castillo; J Rodés
Journal:  Hepatology       Date:  1990-12       Impact factor: 17.425

5.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

Authors:  H Tsukuma; T Hiyama; S Tanaka; M Nakao; T Yabuuchi; T Kitamura; K Nakanishi; I Fujimoto; A Inoue; H Yamazaki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

6.  A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.

Authors:  K Ikeda; S Saitoh; I Koida; Y Arase; A Tsubota; K Chayama; H Kumada; M Kawanishi
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

7.  Prognostic significance of nucleolar organizer regions in hepatocellular carcinoma.

Authors:  K Shimizu; R Izumi; T Ii; K Muraoka; T Inoue; W Fukushima; K Sakamoto; T Tani; T Hashimoto; M Yagi
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

8.  Intratumoral DNA heterogeneity of small hepatocellular carcinoma.

Authors:  S Okada; H Ishii; H Nose; T Okusaka; A Kyogoku; M Yoshimori; M Sakamoto; S Hirohashi
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

9.  Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma.

Authors:  T Oda; H Tsuda; A Scarpa; M Sakamoto; S Hirohashi
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

10.  The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease.

Authors:  S Takase; M Tsutsumi; H Kawahara; N Takada; A Takada
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

View more
  4 in total

1.  Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.

Authors:  Linda-L Wong; Whitney-M Limm; Naoky Tsai; Richard Severino
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 2.  Update on Alcohol and Viral Hepatitis.

Authors:  Stefano Gitto; Giovanni Vitale; Erica Villa; Pietro Andreone
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

3.  Effect of alcohol on clinical complications of hepatitis virus-induced liver cirrhosis: a consecutive ten-year study.

Authors:  Kodjo-Kunale Abassa; Xiao-Ying Wu; Xiu-Ping Xiao; Hao-Xiong Zhou; Yun-Wei Guo; Bin Wu
Journal:  BMC Gastroenterol       Date:  2022-03-19       Impact factor: 3.067

4.  Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization.

Authors:  Attapon Rattanasupar; Arunchai Chang; Tanaporn Prateepchaiboon; Nuttanit Pungpipattrakul; Keerati Akarapatima; Apiradee Songjamrat; Songklod Pakdeejit; Varayu Prachayakul; Teerha Piratvisuth
Journal:  World J Hepatol       Date:  2022-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.